Boston launches Neuroform EZ stent system
This article was originally published in Clinica
Boston Scientific has launched its fourth-generation intracranial aneurysm stent system, Neuroform EZ, in the US and Europe. The device is intended for use in conjunction with endovascular coiling to treat wide-necked aneurysms. It employs the firm's Segmental Expansion technology, which improves anchoring and stability, and is delivered via a simplified, single-operator system which improves placement of the stent, Boston claims. The Natick, Massachusetts company is showcasing the stent at the annual meeting of the Society of Neurointerventional Surgery, which is being held in Carlsbad, California, on 26-30 July.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.